(Sharecast News) - Shares in Smith & Nephew tumbled on Thursday, after the medical devices firm slashed its full-year sales guidance on weaker-than-expected sales in China.
Updating on trading, the blue chip said third-quarter revenues had risen 4% to $1.4bn.

Within that, orthopaedics revenues improved by 2.3% while advanced wound...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE